548 related articles for article (PubMed ID: 30170260)
1. The differential effects of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) on seizure frequency in patients with drug-resistant epilepsy - A randomized, double-blind, placebo-controlled trial.
Ibrahim FAS; Ghebremeskel K; Abdel-Rahman ME; Ahmed AAM; Mohmed IM; Osman G; Elseed M; Hamed A; Rabinowicz AL; Salih MAM; Elbashir MI; Daak AA
Epilepsy Behav; 2018 Oct; 87():32-38. PubMed ID: 30170260
[TBL] [Abstract][Full Text] [Related]
2. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y.
Thies F; Nebe-von-Caron G; Powell JR; Yaqoob P; Newsholme EA; Calder PC
Am J Clin Nutr; 2001 Mar; 73(3):539-48. PubMed ID: 11237929
[TBL] [Abstract][Full Text] [Related]
3. Eicosapentaenoic and docosahexaenoic acids-rich fish oil supplementation attenuates strength loss and limited joint range of motion after eccentric contractions: a randomized, double-blind, placebo-controlled, parallel-group trial.
Tsuchiya Y; Yanagimoto K; Nakazato K; Hayamizu K; Ochi E
Eur J Appl Physiol; 2016 Jun; 116(6):1179-88. PubMed ID: 27085996
[TBL] [Abstract][Full Text] [Related]
4. Effect of omega-3 fatty acid-containing phospholipids on blood catecholamine concentrations in healthy volunteers: a randomized, placebo-controlled, double-blind trial.
Hamazaki K; Itomura M; Huan M; Nishizawa H; Sawazaki S; Tanouchi M; Watanabe S; Hamazaki T; Terasawa K; Yazawa K
Nutrition; 2005 Jun; 21(6):705-10. PubMed ID: 15925295
[TBL] [Abstract][Full Text] [Related]
5. No effect of n-3 fatty acids on high-sensitivity C-reactive protein after myocardial infarction: the Alpha Omega Trial.
Hoogeveen EK; Geleijnse JM; Kromhout D; Giltay EJ
Eur J Prev Cardiol; 2014 Nov; 21(11):1429-36. PubMed ID: 23774275
[TBL] [Abstract][Full Text] [Related]
6. Differential Effects of DHA- and EPA-Rich Oils on Sleep in Healthy Young Adults: A Randomized Controlled Trial.
Patan MJ; Kennedy DO; Husberg C; Hustvedt SO; Calder PC; Middleton B; Khan J; Forster J; Jackson PA
Nutrients; 2021 Jan; 13(1):. PubMed ID: 33467135
[TBL] [Abstract][Full Text] [Related]
7. Supplementation with oil rich in eicosapentaenoic acid, but not in docosahexaenoic acid, improves global cognitive function in healthy, young adults: results from randomized controlled trials.
Patan MJ; Kennedy DO; Husberg C; Hustvedt SO; Calder PC; Khan J; Forster J; Jackson PA
Am J Clin Nutr; 2021 Sep; 114(3):914-924. PubMed ID: 34113957
[TBL] [Abstract][Full Text] [Related]
8. Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans.
Mori TA; Bao DQ; Burke V; Puddey IB; Beilin LJ
Hypertension; 1999 Aug; 34(2):253-60. PubMed ID: 10454450
[TBL] [Abstract][Full Text] [Related]
9. A prospective, randomized, double blind, placebo-controlled evaluation of the effects of eicosapentaenoic acid and docosahexaenoic acid on the clinical signs and erythrocyte membrane polyunsaturated fatty acid concentrations in dogs with osteoarthritis.
Mehler SJ; May LR; King C; Harris WS; Shah Z
Prostaglandins Leukot Essent Fatty Acids; 2016 Jun; 109():1-7. PubMed ID: 27269707
[TBL] [Abstract][Full Text] [Related]
10. Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study.
Yurko-Mauro K; Kralovec J; Bailey-Hall E; Smeberg V; Stark JG; Salem N
Lipids Health Dis; 2015 Sep; 14():99. PubMed ID: 26328782
[TBL] [Abstract][Full Text] [Related]
11. EPA+DHA, but not ALA, Improved Lipids and Inflammation Status in Hypercholesterolemic Adults: A Randomized, Double-Blind, Placebo-Controlled Trial.
Zhou Q; Zhang Z; Wang P; Zhang B; Chen C; Zhang C; Su Y
Mol Nutr Food Res; 2019 May; 63(10):e1801157. PubMed ID: 30900815
[TBL] [Abstract][Full Text] [Related]
12. Effect of fish oil supplementation on quality of life in a general population of older Dutch subjects: a randomized, double-blind, placebo-controlled trial.
van de Rest O; Geleijnse JM; Kok FJ; van Staveren WA; Olderikkert MG; Beekman AT; de Groot LC
J Am Geriatr Soc; 2009 Aug; 57(8):1481-6. PubMed ID: 19549020
[TBL] [Abstract][Full Text] [Related]
13. Circulating CD36+ microparticles are not altered by docosahexaenoic or eicosapentaenoic acid supplementation.
Phang M; Thorne RF; Alkhatatbeh MJ; Garg ML; Lincz LF
Nutr Metab Cardiovasc Dis; 2016 Mar; 26(3):254-60. PubMed ID: 26803595
[TBL] [Abstract][Full Text] [Related]
14. Fish oil (n-3 fatty acids) in drug resistant epilepsy: a randomised placebo-controlled crossover study.
DeGiorgio CM; Miller PR; Harper R; Gornbein J; Schrader L; Soss J; Meymandi S
J Neurol Neurosurg Psychiatry; 2015 Jan; 86(1):65-70. PubMed ID: 25201887
[TBL] [Abstract][Full Text] [Related]
15. Effect of Docosahexaenoic Acid and Eicosapentaenoic Acid Supplementation on Sleep Quality in Healthy Subjects: A Randomized, Double-Blinded, Placebo-Controlled Trial.
Yokoi-Shimizu K; Yanagimoto K; Hayamizu K
Nutrients; 2022 Oct; 14(19):. PubMed ID: 36235788
[TBL] [Abstract][Full Text] [Related]
16. Docosahexaenoic acid reduces resting blood pressure but increases muscle sympathetic outflow compared with eicosapentaenoic acid in healthy men and women.
Lee JB; Notay K; Klingel SL; Chabowski A; Mutch DM; Millar PJ
Am J Physiol Heart Circ Physiol; 2019 Apr; 316(4):H873-H881. PubMed ID: 30735073
[TBL] [Abstract][Full Text] [Related]
17. Oral docosahexaenoic acid in the prevention of exudative age-related macular degeneration: the Nutritional AMD Treatment 2 study.
Souied EH; Delcourt C; Querques G; Bassols A; Merle B; Zourdani A; Smith T; Benlian P;
Ophthalmology; 2013 Aug; 120(8):1619-31. PubMed ID: 23395546
[TBL] [Abstract][Full Text] [Related]
18. Effect of fish-oil supplementation on mental well-being in older subjects: a randomized, double-blind, placebo-controlled trial.
van de Rest O; Geleijnse JM; Kok FJ; van Staveren WA; Hoefnagels WH; Beekman AT; de Groot LC
Am J Clin Nutr; 2008 Sep; 88(3):706-13. PubMed ID: 18779287
[TBL] [Abstract][Full Text] [Related]
19. High-Dose DHA Has More Profound Effects on LDL-Related Features Than High-Dose EPA: The ComparED Study.
Allaire J; Vors C; Tremblay AJ; Marin J; Charest A; Tchernof A; Couture P; Lamarche B
J Clin Endocrinol Metab; 2018 Aug; 103(8):2909-2917. PubMed ID: 29846653
[TBL] [Abstract][Full Text] [Related]
20. Effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular disease risk factors: a randomized clinical trial.
Asztalos IB; Gleason JA; Sever S; Gedik R; Asztalos BF; Horvath KV; Dansinger ML; Lamon-Fava S; Schaefer EJ
Metabolism; 2016 Nov; 65(11):1636-1645. PubMed ID: 27733252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
